/COO
The Cooper Companies, Inc.
COO • NASDAQCOO • NASDAQ • Healthcare
$71.52-3.02%-2.23
$71.52-3.02%(-2.23)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
79Low Risk
Momentum
29Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
60.7%▼6.0pp
Revenue after COGS
Operating
16.7%▼1.4pp
After operating expenses
Net
9.2%▼0.9pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
37.3
Price vs earnings
EV/EBITDA
15.8
Enterprise value
FCF Yield
3.1%
Cash generation
Earnings Yield
2.7%
Inverse of P/E
Capital Efficiency
4
GoAI Quality ScoreWeak
ROEReturn on Equity
4.6%Fair
ROAReturn on Assets
3.0%Fair
ROICReturn on Invested Capital
4.0%Fair
Financial Health
Current RatioHealthy
1.89
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
2.54x
Debt repayment capacity (<3x)
Income QualityStrong
2.12
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Gross Profit | $2.48B | $2.60B | $2.36B | $2.14B | $1.96B |
| Gross Margin | 60.7% | 66.6% | 65.6% | 64.7% | 66.9% |
| Operating Income | $682.90M | $705.70M | $533.10M | $507.60M | $505.80M |
| Net Income | $374.90M | $392.30M | $294.20M | $385.80M | $2.94B |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% |
| EPS | $1.88 | $1.97 | $1.49 | $1.96 | $59.73 |
Average Price Target
$93.86▲ 31.2% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for The Cooper Companies, Inc., the average price target is $93.86, with a high forecast of $100.00 and a low forecast of $73.00. The average price target represents a 31.2% increase from the current price of $71.52.
Highest
$100.00
Average
$93.86
Lowest
$73.00
Rating Distribution
Strong Buy
0
0%
Buy
15
63%
Hold
8
33%
Sell
1
4%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Barclays● Maintain
Overweight
2026-03-06Needham● Maintain
Buy
2026-03-06Citigroup● Maintain
Neutral
2026-03-06Needham● Maintain
Buy
2026-02-03Barclays● Maintain
Overweight
2026-01-26Morgan Stanley● Maintain
Equal Weight
2025-12-08Goldman Sachs● Maintain
Sell
2025-12-08Citigroup● Maintain
Neutral
2025-12-08Mizuho● Maintain
Outperform
2025-12-05Wells Fargo● Maintain
Equal Weight
2025-12-05Earnings History & Surprises
BEAT RATE
67%
Last 18 quarters
AVG SURPRISE
+2.1%
EPS vs Estimate
BEATS / MISSES
12/3
3 met exactly
LATEST EPS
$1.10
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+6.8%
$1.10 vs $1.03
Q4 '25
+3.6%
$1.15 vs $1.11
Q3 '25
+2.8%
$1.10 vs $1.07
Q2 '25
+3.4%
$0.96 vs $0.93
Q1 '25
+0.7%
$0.92 vs $0.91
Q4 '24
+4.0%
$1.04 vs $1.00
Q3 '24
+5.4%
$0.96 vs $0.91
Q2 '24
+2.5%
$0.85 vs $0.83
Q1 '24
+8.6%
$0.85 vs $0.78
Q4 '23
$0.87 vs $0.87
Q3 '23
$0.84 vs $0.84
Q2 '23
+2.7%
$0.77 vs $0.75
No investor questions available.
Latest News
No news available